SonoClear secures MNOK 10

Bergen, May 16, 2019

SonoClear has just secured NOK 10mill (€ 1,1mill) from existing and new investors. The main investors in this round were, Sarsia Seed Fund II, Sintef Venture IV, Co-Founder and Sparebank1 Midt-Norge. The funding will be used to cover further development costs for SonoClear’s intraoperative ultrasound contact fluid and for regulatory activities to get the product approved for clinical use during neurosurgical procedures in US and EU.